These results suggest an important pathway in regulating cell death in AD, and potentially in other neurodegenerative diseases, because MET and HGF were also differentially abundant in non-AD neurodegenerative diseases compared with the A−T− group. The gene discussed is MET; the disease is Alzheimer disease.